Armata Pharmaceuticals (ARMP) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.69% |
| Dec 31, 2025 | 2.08% |
| Sep 30, 2025 | 1.40% |
| Jun 30, 2025 | 26.31% |
| Mar 31, 2025 | 13.55% |
| Dec 31, 2024 | -9.02% |
| Sep 30, 2024 | -14.55% |
| Jun 30, 2024 | -14.89% |
| Mar 31, 2024 | -43.78% |
| Dec 31, 2023 | -6.95% |
| Sep 30, 2023 | -12.33% |
| Jun 30, 2023 | 4.18% |
| Mar 31, 2023 | -25.06% |
| Dec 31, 2022 | -23.68% |
| Sep 30, 2022 | -26.86% |
| Jun 30, 2022 | -32.77% |
| Mar 31, 2022 | -83.97% |
| Dec 31, 2021 | -14.92% |
| Sep 30, 2021 | -24.94% |
| Jun 30, 2021 | -19.67% |
| Mar 31, 2021 | -29.47% |
| Dec 31, 2020 | -0.59% |
| Sep 30, 2020 | -6.24% |
| Jun 30, 2020 | -6.63% |
| Mar 31, 2020 | -7.81% |
| Dec 31, 2019 | 1.72% |
| Sep 30, 2019 | 2.35% |
| Jun 30, 2019 | -1.00% |
| Mar 31, 2019 | 17.82% |
| Dec 31, 2018 | 13.84% |
| Sep 30, 2018 | -22.48% |
| Jun 30, 2018 | -15.87% |
| Mar 31, 2018 | -62.73% |